Rare diseases
Investigational molecules
Locations
Recruiting trials first
2 clinical trials in this condition
ItalyItalyIn short
Breast cancer in situ, also called ductal carcinoma in situ or DCIS, represents the earliest form of breast cancer where abnormal cells remain confined within the milk ducts and have not spread into surrounding breast tissue. While receiving this diagnosis can feel overwhelming, it's important to understand that this condition is highly treatable and has an excellent outlook when properly addressed.
If you have been diagnosed with breast cancer in situ, it's natural to feel worried about what lies ahead. However, the outlook for this condition is remarkably positive, and this information should provide some reassurance during this difficult time. The 10-year survival rate for people diagnosed with DCIS is approximately 98%, regardless of whether they receive treatment beyond surgery. This means that practically all patients with this stage of breast cancer can be cured.
Because DCIS is considered stage 0 breast cancer, the cancer cells have not invaded the surrounding breast tissue or spread to other parts of the body. This containment within the milk ducts means the condition is highly treatable, and the prognosis is excellent. The main goal of treatment is not necessarily to improve survival, since survival rates are already very high, but rather to prevent the condition from potentially developing into invasive breast cancer in the future.
It's important to understand that while DCIS itself is not life-threatening, it does require evaluation and consideration of treatment options. Your healthcare team will work with you to develop a treatment plan that takes into account the characteristics of your specific case, including the grade of the cells, the size of the affected area, and your personal preferences and circumstances.
Understanding what might happen if breast cancer in situ is left untreated can help you make informed decisions about your care. Without treatment, there is a possibility that DCIS could progress to invasive breast cancer over time. Research suggests that somewhere between 10% and 50% of DCIS cases may develop into invasive breast cancer if not treated, though more recent modeling studies suggest the range could be even wider, from 36% to 100% of cases.
The challenge healthcare providers face is that they cannot currently predict which cases will progress to invasive cancer and which will remain unchanged. This uncertainty is one of the main reasons why almost all cases of DCIS are treated. When cells remain confined to the milk ducts, they cannot spread to other parts of the body. However, if these abnormal cells break through the walls of the milk ducts and spread into the surrounding breast tissue, the cancer becomes invasive.
The time frame for potential progression varies considerably. Some research models suggest that progression from DCIS to invasive breast cancer, when it occurs, typically takes between 0.2 to 2.5 years. The grade of DCIS plays a role in this progression risk. High-grade DCIS, where cells look very abnormal under a microscope and grow more quickly, is thought to be more likely to develop into invasive cancer compared to low-grade DCIS.
The most significant complication associated with breast cancer in situ is its potential transformation into invasive ductal carcinoma if left untreated. This transformation represents a major change in the nature of the disease, as invasive cancer has the ability to spread beyond the breast to lymph nodes and other organs in the body. This is why timely treatment is so important.
After receiving treatment for DCIS, there is a possibility of recurrence, meaning the abnormal cells could return. The cancer can come back either as DCIS again or as invasive breast cancer. Treatment with surgery alone, or surgery combined with radiation therapy or hormone therapy, aims to reduce this risk of recurrence. For example, radiation therapy after breast-conserving surgery can cut the risk of recurrence by about half, while hormone therapy can reduce it by about a quarter.
If you have been treated for DCIS, you face a higher risk of developing certain health conditions as you age. These may include osteoporosis (a condition where bones become weak and brittle), high blood pressure, and heart disease. These risks highlight the importance of ongoing medical follow-up even after successful treatment. Regular screenings and monitoring can help detect these conditions early when they are most manageable.
Some treatments for DCIS can also cause side effects that, while not life-threatening, can affect your quality of life. For instance, if lymph nodes are removed during surgery, there is a risk of developing lymphedema, which is swelling in the arm caused by a buildup of lymph fluid. Radiation therapy can cause skin changes and fatigue. These potential complications should be discussed with your healthcare team so you can weigh the benefits and risks of different treatment approaches.
A diagnosis of breast cancer in situ can affect many aspects of your daily life, from your physical health to your emotional well-being, relationships, work, and leisure activities. Understanding these potential impacts can help you prepare and find ways to cope during treatment and recovery.
Physically, the treatments for DCIS can temporarily limit your activities. Surgery, whether it's a lumpectomy (removal of the tumor and some surrounding tissue) or mastectomy (removal of the entire breast), requires recovery time during which you may need to limit arm movements and avoid heavy lifting. If you undergo radiation therapy, you may experience fatigue that makes it harder to keep up with your usual routine. The treatment typically lasts three to four weeks, during which you'll need to attend daily sessions.
Emotionally, dealing with a cancer diagnosis is challenging, even when the prognosis is excellent. Many people experience anxiety, fear, and uncertainty about the future. You might worry about the possibility of recurrence or about how treatment will affect your body image, especially if you're considering mastectomy. These feelings are completely normal and valid. Some women find that participating in support groups, talking with a counselor, or connecting with others who have been through similar experiences helps them cope.
Your relationships with family and friends may be affected as well. Loved ones may want to help but might not know how, or you might find it difficult to communicate your needs and feelings. Being open about what you're going through and what kind of support would be helpful can strengthen these relationships. On the other hand, some people may struggle to understand that while DCIS is serious, it's also highly curable, which can create tension or miscommunication.
Work and financial considerations are also important. You may need to take time off for surgery and recovery, and if you're receiving radiation therapy, you'll need to schedule regular appointments. Some employers are very understanding and accommodating, while others may be less flexible. If you're self-employed or don't have paid sick leave, the financial impact of treatment can add stress to an already difficult situation. Speaking with a social worker or patient navigator at your treatment facility can help you explore options for financial assistance or workplace accommodations.
Many people find that hobbies and activities they once enjoyed are temporarily affected during treatment and recovery. Physical activities may be limited after surgery, and fatigue from radiation can make it harder to engage in social activities or pursue interests. However, most people are able to gradually return to their normal activities as they recover. Some individuals actually find new interests or prioritize activities differently after going through treatment, focusing more on what brings them joy and fulfillment.
When someone is diagnosed with breast cancer in situ, it affects not just the patient but their entire family. Family members and close friends play a crucial role in providing support throughout the diagnosis, treatment, and recovery process. Understanding how to help can make a significant difference in the patient's experience and outcomes.
One of the most important things family members can do is educate themselves about DCIS. Understanding that this is a highly treatable condition with an excellent prognosis can help alleviate some of the fear and anxiety that comes with hearing the word "cancer." At the same time, it's important to recognize that even though DCIS has a good outlook, it's still a serious diagnosis that requires treatment and can be emotionally difficult for the person going through it.
Practical support is invaluable during treatment. This might include driving the patient to medical appointments, helping with household chores, preparing meals, or caring for children. After surgery, the patient may have restrictions on lifting and arm movements, so assistance with daily tasks becomes especially important. Sometimes the most helpful thing is simply being present and available, whether that means sitting in the waiting room during appointments or just spending quiet time together.
Emotional support is equally crucial. Listening without judgment, allowing the patient to express fears and concerns, and offering reassurance can help ease the emotional burden. However, it's important to let the patient take the lead in conversations about their diagnosis and treatment. Some people want to talk about it extensively, while others prefer to focus on other topics. Respecting their preferences and following their cues helps them feel supported without being overwhelmed.
If clinical trials are being considered as part of treatment, family members can help by researching trial options, asking questions about what participation would involve, and helping the patient weigh the potential benefits and risks. Clinical trials can offer access to innovative treatments and contribute to advancing medical knowledge, but they're not right for everyone. Family members can assist by gathering information from healthcare providers about available trials, helping to understand eligibility requirements, and discussing how trial participation might affect daily life and treatment schedules.
It's also important for family members to take care of themselves during this time. Supporting someone through cancer treatment can be emotionally and physically draining. Seeking support from friends, joining a caregiver support group, or talking with a counselor can help family members manage their own stress and maintain their ability to provide support. Remember that taking care of yourself isn't selfish—it's necessary to be able to effectively support your loved one.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
